Z Gastroenterol 2021; 59(01): e25
DOI: 10.1055/s-0040-1722014
Poster Visit Session II Clinical Hepatology, Surgery, LTX
Friday, January 29, 2021 2:40 pm – 3:25 pm, Poster Session Virtual Venue

Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis

MM Mücke
1   University Hospital Frankfurt, Department of Internal Medicine 1, Frankfurt, Germany
,
S Rüschenbaum
2   University Hospital Essen, Department for Gastroenterology and Hepatology, Essen, Germany
,
A Mayer
1   University Hospital Frankfurt, Department of Internal Medicine 1, Frankfurt, Germany
,
VT Mücke
1   University Hospital Frankfurt, Department of Internal Medicine 1, Frankfurt, Germany
,
KM Schwarzkopf
1   University Hospital Frankfurt, Department of Internal Medicine 1, Frankfurt, Germany
,
S Zeuzem
1   University Hospital Frankfurt, Department of Internal Medicine 1, Frankfurt, Germany
,
J Kehrmann
3   University Hospital Essen, Institute of Medical Microbiology, Essen, Germany
,
R Scholtysik
4   Universitätsklinikum Essen, Institut für Zellbiologie, Essen, Germany
,
CM Lange
2   University Hospital Essen, Department for Gastroenterology and Hepatology, Essen, Germany
› Author Affiliations
 

Introduction Quinolone prophylaxis is recommended for patients with advanced cirrhosis at high risk of spontaneous bacterial peritonitis (SBP) or with prior SBP. Yet, the impact of long-term antibiotic prophylaxis on the microbiome of these patients is poorly characterized.

Methods Patients with liver cirrhosis receiving long-term quinolone prophylaxis to prevent SBP were prospectively included and sputum and stool samples were obtained at baseline, one, four and twelve weeks thereafter. Both bacterial DNA and RNA were assessed with 16S rRNA sequencing. Relative abundance, alpha and beta diversity were calculated and correlated with clinical outcome.

Results Overall, 35 stool and 19 sputum samples were obtained from 11 patients. Two patients died (day 9 and 12) all others were followed for 180 days. Reduction of Shannon diversity and bacterial richness was insignificant after initiation of quinolone prophylaxis (p > 0.05). Gut microbiota were significantly different between patients (p < 0.001) but non-significantly altered between the different time points before and after initiation of antibiotic prophylaxis (p > 0.05). A high relative abundance of Enterobacteriaceae  > 20 % during quinolone prophylaxis was found in three patients. Specific clinical scenarios (development of secondary infections during antibiotic prophylaxis or the detection of multidrug-resistant Enterobacteriaceae) characterized these patients. Sputum microbiota were not significantly altered in individuals during prophylaxis.

Conclusion Inter-individual differences in alpha and beta diversity of gut microbiota were high at baseline, yet quinolone prophylaxis had only a moderate impact on gut microbiota diversity. High relative abundances of Enterobacteriaceae during follow-up might indicate failure of or non-adherence to quinolone prophylaxis. Future studies are needed to further investigate this phenomenon and to tailor individual prophylactic strategies in these patients.



Publication History

Article published online:
04 January 2021

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany